Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-12-13
1997-02-11
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514279, 514283, 544233, 546 41, 546 51, 546 70, C07D47104, C07D47114, A61K 3150, A61K 3144
Patent
active
056021313
ABSTRACT:
A compound selected from those of general formula (I): ##STR1## wherein A represents a bivalent radical selected from ##STR2## and R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.9 and Z are as defined in the description,
REFERENCES:
patent: 3454583 (1969-07-01), Kuehne
Debure, et al., Somatotopic orgainzation of tyrosine hydroxylase expression in the rat locus coeruleus: long term effect of RU24722, Brain Research 581, 19-32 (1992).
Reis, et al., Reserpine selectively increases tyrosine hydroxylase and dopanime, Brain Research 81, 380-386 (1974).
Zigmond, Biochemical consequences of synaptic stimulation: The regulation of tyrosine hydroxylase activity by multiple transmitters, TINS, 63-69 (Feb. 1995).
Mitchell, et al., Increases in tyrosine hydroxylase messenger RNA in the locus coeruleus after a single dose of nicotine are followed by time-dependent increases in enzyme activity and noradrenaline release, Neuroscience 56, No. 4, 989-997 (1993).
Nisenbaum, et al., Prior Exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor, The Journal of Neuroscience 11(5), 1478-1484 (May 1991).
Nisenbaum, et al., Enhanced tyrosine hydroxylation in hippocampus of chronically stressed rates upon exposure to a novel stressor, Journal of Neurochemistry 58(1), 276-281 (1992).
Zornetzer, Catecholamine system involvement in age-related memory disfunction, Annals New York Academy of Sciences, 242-254 (1985).
Arnsten, et al., Catecholamines and Cognitive Decline in Aged Nonhuman Primates, Annals New York Academy of Sciences, 218-234 (1985).
Boundareff, Neuropathology of Nucleas Basalis and Locus Ceruleus in Alzheimer's Disease, The Biological Substrates of Alzheimer's Disease, 101-113 (1986).
Chan-Palay, Alterations in catecholamine neurons in the locus coeruleus in dementias of Alzheimer's and Parkinson's diseases, Neural Transmissions 1, 19-20 (1989).
Mason, et al., Reward, attention and the dorsal noradrenergic bundle, Brain Research 150, 135-148 (1978).
Olpe, et al., Locus coeruleus as a target for psychogeriatric agents, Annals New York Academy of Sciences, 394-405 (1985).
Siever, et al., Overview: toward a dysregulation hypothesis of depression, Am. J. Psychiatry 142:9, 1017-1031 (Sep. 1985).
Nestler, et al., Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus coeruleus, Proc. Natl. Acad. Sci. USA 87, 7522-7526 (Oct. 1990).
Brady, et al., The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications, Brian Research 572, 117-125 (1992) .
Brion Jean-Daniel
Demuynck Luc
Lepagnol Jean
Lestage Pierre
Parmentier Jean-Gilles
Adir et Compagnie
Bernhardt Emily
LandOfFree
EburnanE analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with EburnanE analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and EburnanE analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342307